# An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial

*PRI Rank #16 · Topics and Trends in Most Cited Animal Virus Infections Studies Papers, Class of 2026*

*Canonical URL: https://pri.pepkio.com/top-papers/animal-virus-infections-studies/2026/rank-16*

| Field | Value |
| --- | --- |
| Rank | #16 |
| 18m citations | 50 |
| Journal | Nature Medicine |
| Year | 2024 |
| DOI | 10.1038/s41591-024-02955-2 |
| Corresponding authors | Sanjay Singh |
| Institution | Gennova Biopharmaceuticals Limited, India |

**Ranking page:** [Topics and Trends in Most Cited Animal Virus Infections Studies Papers, Class of 2026](https://pri.pepkio.com/top-papers/animal-virus-infections-studies/2026)

**Paper link:** [10.1038/s41591-024-02955-2](https://doi.org/10.1038/s41591-024-02955-2)

## Topics

GEMCOVAC-OM · self-amplifying mRNA vaccine · Omicron BA.1 · B.1.1.529 · Intradermal administration · thermostable vaccine · BBV152 · ChAdOx1 nCoV-19 · GEMCOVAC-19 · D614G variant · anti-spike IgG antibodies · Neutralizing antibodies · Neutralization assay · seroconversion · Booster vaccination · Phase 2/3 trial · Monovalent vaccine · variant-specific immunogenicity

## Cite this ranking

```
Pepkio Research Index (PRI). Topics and Trends in Most Cited Animal Virus Infections Studies Papers, Class of 2026. https://pri.pepkio.com/top-papers/animal-virus-infections-studies/2026. Accessed 2026-10-29.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
```